[{"Assets_0_Q2_USD":2099653000.0,"CommonStockSharesOutstanding_0_Q2_shares":174966000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-134817000.0,"NetIncomeLoss_1_Q2_USD":-109909000.0,"NetIncomeLoss_2_Q2_USD":-228421000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":174549000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":174206000.0,"StockholdersEquity_0_Q2_USD":1557155000.0,"EarningsPerShareBasic_1_Q2_USD":-0.63,"EarningsPerShareBasic_2_Q2_USD":-1.31,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190809"}]